Inspire Medical Systems, Inc.
INSP- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001609550
In the last 90 days, Inspire Medical Systems, Inc. insiders filed 0 open-market purchases and 1 sale; 275 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Inspire Medical Systems, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 254 | 2 | 289 | +37 |
| Shares | 25.4M | 320.7K | 25.9M | +785.1K (+3.1%) |
| Value | $5.91B | $74.7M | $5.95B | +$111.0M (+1.9%) |
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (53)
Institutions that held Inspire Medical Systems, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (16)
Institutions that held Inspire Medical Systems, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Cormorant Asset Management, LP | 48,132 | $11.2M |
| Balyasny Asset Management LLC | 27,250 | $6.35M |
| Natixis | 10,726 | $2.50M |
| Integral Health Asset Management, LLC | 10,000 | $2.33M |
| EAM Investors, LLC | 9,993 | $2.33M |
| ETF Managers Group, LLC | 6,311 | $1.41M |
| Penserra Capital Management LLC | 5,652 | $1.32M |
| Gotham Asset Management, LLC | 3,683 | $858.0K |
| Blueshift Asset Management, LLC | 3,235 | $753.0K |
| Walleye Trading LLC | 1,079 | $251.0K |
| Point72 Hong Kong Ltd | 878 | $204.0K |
| Cahill Financial Advisors Inc | 375 | $87.0K |
| PEAK6 Investments LLC | 312 | $73.0K |
| Atticus Wealth Management, LLC | 229 | $53.0K |
| Gerber Kawasaki Wealth & Investment Management | 145 | $33.0K |
| Meridian Wealth Partners, LLC | 6 | $1.00K |
Not filed for Q4 2021 yet (2)
Institutions that held Inspire Medical Systems, Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 320,657 | $74.7M |
| Berman Capital Advisors, LLC | 51 | $11.0K |